Tearsheet
CL Home Investment Highlights Valuation, Metrics & Events Price Chart Why The Stock Moved Return vs. Risk About CL Interactive Breakdown Better Bets vs. CL Latest Trefis Analyses Trade Ideas More From Trefis Peer Comparisons FDIC Bank Data FDA Approved Drugs Data Financials Segment Financials Price Behavior Short Interest Earnings Returns History SEC Filings Forward Guidance Insider Activity Trade Sentinel Industry Resource Links External Quote Links

Colgate-Palmolive (CL)

Market Price (4/18/2026): $85.81 | Market Cap: $69.1 Bil
Sector: Consumer Staples | Industry: Household Products

Colgate-Palmolive (CL)

Market Price (4/18/2026): $85.81
Market Cap: $69.1 Bil
Sector: Consumer Staples
Industry: Household Products

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

0

Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 5.7%, Dividend Yield is 2.6%, FCF Yield is 5.3%

Attractive operating margins
Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is 21%

Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 21%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 18%, CFO LTM is 4.2 Bil, FCF LTM is 3.6 Bil

Stock buyback support
Stock Buyback 3Y Total is 4.1 Bil

Low stock price volatility
Vol 12M is 21%

Megatrend and thematic drivers
Megatrends include E-commerce & DTC Adoption, Sustainable Consumption, Circular Economy & Recycling, Health & Wellness Trends, Show more.

Weak multi-year price returns
2Y Excs Rtn is -34%, 3Y Excs Rtn is -53%

Key risks
CL key risks include [1] gross margin pressure from volatile commodity input costs and foreign exchange rates, Show more.

0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 5.7%, Dividend Yield is 2.6%, FCF Yield is 5.3%
1 Attractive operating margins
Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is 21%
2 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 21%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 18%, CFO LTM is 4.2 Bil, FCF LTM is 3.6 Bil
3 Stock buyback support
Stock Buyback 3Y Total is 4.1 Bil
4 Low stock price volatility
Vol 12M is 21%
5 Megatrend and thematic drivers
Megatrends include E-commerce & DTC Adoption, Sustainable Consumption, Circular Economy & Recycling, Health & Wellness Trends, Show more.
6 Weak multi-year price returns
2Y Excs Rtn is -34%, 3Y Excs Rtn is -53%
7 Key risks
CL key risks include [1] gross margin pressure from volatile commodity input costs and foreign exchange rates, Show more.

Valuation, Metrics & Events

Price Chart

Why The Stock Moved

Qualitative Assessment

AI Analysis | Feedback

Colgate-Palmolive (CL) stock has gained about 10% since 12/31/2025 because of the following key factors:

1. Strong Q4 2025 Earnings Beat Exceeded Analyst Expectations. Colgate-Palmolive reported robust fourth-quarter 2025 financial results on January 30, 2026, surpassing analyst consensus. The company's adjusted earnings per share (EPS) of $0.95 exceeded estimates of $0.91 by 4.2%. Additionally, revenue reached $5.23 billion, beating analyst projections of $5.13 billion by 1.7% and demonstrating a 5.8% increase year-on-year. Organic revenue also grew by 2.2% year-on-year.

2. Favorable Analyst Upgrades and Increased Price Targets Boosted Sentiment. Several prominent financial institutions upgraded their ratings and raised price targets for Colgate-Palmolive, signaling a positive outlook. Deutsche Bank, for example, upgraded the stock from "hold" to "buy" on March 30, 2026, simultaneously increasing its price target from $90.00 to $98.00. Similarly, Morgan Stanley elevated its price objective to $100.00 on February 2, 2026. The consensus price target among analysts during this period ranged from approximately $95.25 to $96.65, indicating a strong positive market sentiment.

Show more
Holding a concentrated position? Know your true downside before the momentum shifts.
Protect Your Wealth →

Stock Movement Drivers

Fundamental Drivers

The 9.3% change in CL stock from 12/31/2025 to 4/17/2026 was primarily driven by a 48.5% change in the company's P/E Multiple.
(LTM values as of)123120254172026Change
Stock Price ($)78.5485.819.3%
Change Contribution By: 
Total Revenues ($ Mil)20,09720,3821.4%
Net Income Margin (%)14.5%10.5%-27.7%
P/E Multiple21.832.448.5%
Shares Outstanding (Mil)8088050.4%
Cumulative Contribution9.3%

LTM = Last Twelve Months as of date shown

Market Drivers

12/31/2025 to 4/17/2026
ReturnCorrelation
CL9.3% 
Market (SPY)-5.4%3.2%
Sector (XLP)6.2%80.1%

Fundamental Drivers

The 8.7% change in CL stock from 9/30/2025 to 4/17/2026 was primarily driven by a 47.4% change in the company's P/E Multiple.
(LTM values as of)93020254172026Change
Stock Price ($)78.9285.818.7%
Change Contribution By: 
Total Revenues ($ Mil)19,99920,3821.9%
Net Income Margin (%)14.5%10.5%-28.1%
P/E Multiple22.032.447.4%
Shares Outstanding (Mil)8108050.7%
Cumulative Contribution8.7%

LTM = Last Twelve Months as of date shown

Market Drivers

9/30/2025 to 4/17/2026
ReturnCorrelation
CL8.7% 
Market (SPY)-2.9%-10.2%
Sector (XLP)6.1%76.3%

Fundamental Drivers

The -6.2% change in CL stock from 3/31/2025 to 4/17/2026 was primarily driven by a -27.3% change in the company's Net Income Margin (%).
(LTM values as of)33120254172026Change
Stock Price ($)91.4585.81-6.2%
Change Contribution By: 
Total Revenues ($ Mil)20,10120,3821.4%
Net Income Margin (%)14.4%10.5%-27.3%
P/E Multiple25.832.425.5%
Shares Outstanding (Mil)8168051.4%
Cumulative Contribution-6.2%

LTM = Last Twelve Months as of date shown

Market Drivers

3/31/2025 to 4/17/2026
ReturnCorrelation
CL-6.2% 
Market (SPY)16.3%5.7%
Sector (XLP)3.2%75.3%

Fundamental Drivers

The 22.6% change in CL stock from 3/31/2023 to 4/17/2026 was primarily driven by a 13.4% change in the company's Total Revenues ($ Mil).
(LTM values as of)33120234172026Change
Stock Price ($)70.0085.8122.6%
Change Contribution By: 
Total Revenues ($ Mil)17,96720,38213.4%
Net Income Margin (%)9.9%10.5%5.2%
P/E Multiple32.632.4-0.7%
Shares Outstanding (Mil)8328053.4%
Cumulative Contribution22.6%

LTM = Last Twelve Months as of date shown

Market Drivers

3/31/2023 to 4/17/2026
ReturnCorrelation
CL22.6% 
Market (SPY)63.3%5.9%
Sector (XLP)19.1%71.6%

Return vs. Risk

Price Returns Compared

 202120222023202420252026Total [1]
Returns
CL Return2%-5%4%17%-11%6%11%
Peers Return11%-3%-1%12%-22%-1%-8%
S&P 500 Return27%-19%24%23%16%3%87%

Monthly Win Rates [3]
CL Win Rate42%50%50%75%42%50% 
Peers Win Rate52%45%48%57%27%50% 
S&P 500 Win Rate75%42%67%75%67%50% 

Max Drawdowns [4]
CL Max Drawdown-12%-18%-11%0%-16%-3% 
Peers Max Drawdown-11%-22%-12%-3%-24%-7% 
S&P 500 Max Drawdown-1%-25%-1%-2%-15%-7% 

[1] Cumulative total returns since the beginning of 2021
[2] Peers: PG, KMB, CHD, CLX, GIS. See CL Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 4/17/2026 (YTD)

How Low Can It Go

Unique KeyEventCLS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-19.8%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven24.6%34.1%
2022 Inflation ShockTime to BreakevenTime to Breakeven479 days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-22.6%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven29.2%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven146 days148 days
2018 Correction2018 Correction  
2018 Correction% Loss% Loss-25.2%-19.8%
2018 Correction% Gain to Breakeven% Gain to Breakeven33.7%24.7%
2018 CorrectionTime to BreakevenTime to Breakeven659 days120 days
2008 Global Financial Crisis2008 Global Financial Crisis  
2008 Global Financial Crisis% Loss% Loss-31.5%-56.8%
2008 Global Financial Crisis% Gain to Breakeven% Gain to Breakeven46.0%131.3%
2008 Global Financial CrisisTime to BreakevenTime to Breakeven378 days1,480 days

Compare to PG, KMB, CHD, CLX, GIS

In The Past

Colgate-Palmolive's stock fell -19.8% during the 2022 Inflation Shock from a high on 12/31/2021. A -19.8% loss requires a 24.6% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Colgate-Palmolive (CL)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

AI Analysis | Feedback

Colgate-Palmolive is like a global Procter & Gamble (PG) that also owns a major pet food company.

Colgate-Palmolive is similar to Unilever (UL), but with a strong emphasis on oral hygiene and pet nutrition brands.

AI Analysis | Feedback

  • Oral Care Products: Includes toothpastes, toothbrushes, mouthwashes, and professional dental products for oral hygiene.
  • Personal Care Products: Encompasses soaps, shower gels, shampoos, conditioners, deodorants, antiperspirants, and skin health products for personal grooming.
  • Home Care Products: Covers dishwashing detergents, fabric conditioners, and household cleaners for maintaining home cleanliness.
  • Pet Nutrition Products (Everyday): Offers pet food for the daily nutritional needs of dogs and cats under the Hill's Science Diet brand.
  • Pet Nutrition Products (Therapeutic): Provides specialized pet food to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand.

AI Analysis | Feedback

Colgate-Palmolive (CL) sells its products primarily to other companies, which then distribute and sell them to individual consumers. Its major customers are large retailers (both traditional brick-and-mortar and e-commerce), wholesalers, distributors, pet supply retailers, veterinarians, and oral health professionals.

Major customer companies for Colgate-Palmolive include:

  • Walmart Inc. (WMT)
  • Amazon.com, Inc. (AMZN)
  • The Kroger Co. (KR)
  • Target Corporation (TGT)
  • Petco Health and Wellness Company, Inc. (WOOF)
  • Chewy, Inc. (CHWY)

AI Analysis | Feedback

null

AI Analysis | Feedback

Noel Wallace, Chairman, President and Chief Executive Officer

Noel Wallace became President and Chief Executive Officer in 2019 and Chairman in 2020. He joined Colgate-Palmolive in 1987 and progressed through a series of senior management roles around the world, including President and Chief Operating Officer. He serves on the Board of Directors of American Express and previously served on the Board of Directors of The Kellogg Company (now Kellanova) from 2015 to 2018.

Stanley J. Sutula III, Chief Finance Officer

Stan Sutula joined Colgate-Palmolive in 2020 as Chief Finance Officer. Prior to this, he served as Executive Vice President and Chief Financial Officer at Pitney Bowes Inc. from February 2017 to November 2020. He spent 28 years at IBM Corporation in various financial management roles, culminating in his service as Vice President and Controller. Mr. Sutula is also on the board of Avaya Holdings Corp.

Jennifer M. Daniels, Chief Legal Officer and Secretary

Jennifer M. Daniels serves as Colgate-Palmolive's Chief Legal Officer and Secretary.

Shane Grant, Chief Operating Officer, Americas

Shane Grant holds the position of Chief Operating Officer, Americas, at Colgate-Palmolive.

John Hazlin, Chief Growth Officer

John Hazlin is Colgate-Palmolive's Chief Growth Officer.

AI Analysis | Feedback

Colgate-Palmolive Company (CL) faces several key risks inherent to its global consumer products business. These risks, ranging from intense market competition to macroeconomic pressures and supply chain vulnerabilities, could impact its financial performance and market position.

1. Intense Competition and Shifting Consumer Preferences

Colgate-Palmolive operates in a highly competitive consumer goods sector, facing significant pressure from global rivals like Procter & Gamble and Unilever, as well as a growing threat from lower-priced private label brands. Consumers are increasingly price-sensitive, particularly in inflationary environments, leading to a trend of "trading down" to more affordable alternatives. Additionally, evolving consumer preferences, such as the rising demand for sustainable and eco-friendly products, necessitate continuous innovation and adaptation in product formulations and packaging, requiring substantial investment in research and development and marketing.

2. Macroeconomic Headwinds

As a global company with a majority of its sales derived from outside the U.S., Colgate-Palmolive's earnings are vulnerable to macroeconomic factors. Rising costs for raw materials and shipping persistently pressure profitability, especially if these increases cannot be fully passed on to consumers. Unfavorable currency movements, particularly a strong U.S. dollar, can significantly impact reported revenue and net income when international sales are converted back to USD. Economic slowdowns in key international markets, especially emerging markets which are critical growth drivers, can also lead to reduced consumer spending and demand for its products.

3. Supply Chain Disruptions and Input Cost Volatility

The company is exposed to risks related to supply chain vulnerabilities, which can stem from geopolitical events, natural disasters, or other disruptions. Furthermore, the volatility of raw material prices, such as fats and oils, resins, and packaging materials, can squeeze profit margins if the company cannot effectively manage these fluctuating costs. Reliance on single-source suppliers for certain key materials also presents an additional risk to consistent product availability and quality.

AI Analysis | Feedback

The rise of fresh, human-grade, and direct-to-consumer pet food brands poses an emerging threat to Colgate-Palmolive's Hill's Pet Nutrition segment. These new market entrants, such as The Farmer's Dog and Ollie, offer a fundamentally different product and distribution model compared to traditional kibble and canned pet food. They cater to a growing consumer demand for more natural, less processed, and often personalized pet nutrition, directly challenging Hill's established brands like Science Diet and Prescription Diet.

AI Analysis | Feedback

Colgate-Palmolive Addressable Markets

Colgate-Palmolive (CL) operates in several large addressable markets globally and within the U.S. The market sizes for its main product segments are as follows:

Oral Care

  • The global oral care market was valued at approximately USD 43.29 billion in 2025 and is projected to increase to USD 83.12 billion by 2035.
  • In the U.S., the oral care market was estimated at USD 10.03 billion in 2024 and is projected to reach USD 13.02 billion by 2030.

Personal Care

  • The global beauty and personal care products market size was valued at around USD 601.39 billion in 2024 and is projected to reach USD 1232.57 billion by 2034.
  • The U.S. beauty and personal care products market size was valued at USD 136.03 billion in 2024 and is expected to expand to USD 195.83 billion by 2033.

Home Care

  • The global home care market, which includes products such as dish care, fabric care, and surface care, was valued at USD 160.89 billion in 2024. It is projected to grow to USD 252.43 billion by 2032.
  • The addressable market size for U.S. home care products is null, as available data primarily refers to home healthcare services rather than consumer home cleaning and maintenance products.

Pet Nutrition

  • The global pet food market is projected to grow from USD 132.4 billion in 2025 to USD 247.7 billion by 2035.
  • The U.S. pet food market size reached USD 41.59 billion in 2025, with projections indicating a rise to approximately USD 68.33 billion by 2035.
  • More specifically, for therapeutic pet nutrition, the global pet therapeutic diet market was valued at USD 4.3 billion in 2024 and is projected to grow to USD 8.8 billion by 2034.
  • The U.S. pet therapeutic diet market was estimated at USD 1.8 billion in 2024 and is expected to grow to USD 3.6 billion by 2034.

AI Analysis | Feedback

Colgate-Palmolive (CL) is expected to drive future revenue growth over the next 2-3 years through several key strategies:

  1. Strategic Pricing and Revenue Growth Management (RGM): The company consistently implements strategic pricing actions to offset inflationary pressures and enhance organic sales growth across its product portfolio. This approach allows Colgate-Palmolive to maintain and improve its revenue despite fluctuating costs and dynamic market conditions.
  2. Innovation and Premiumization Across Product Categories: Colgate-Palmolive is focusing on impactful, science-based innovation across various price tiers, including the expansion into premium segments. This strategy is visible in both its Oral, Personal, and Home Care as well as its Pet Nutrition segments, where new and improved products are launched to meet evolving consumer demands and drive higher-value sales.
  3. Expansion and Strong Performance in Emerging Markets: A significant portion of Colgate-Palmolive's growth is anticipated from its strong presence and continued expansion in faster-growing emerging markets. Regions such as Latin America (particularly Mexico and Brazil) and Africa/Eurasia have demonstrated robust organic growth, with emerging markets overall contributing significantly to the company's revenue momentum.
  4. Growth in the Pet Nutrition Segment: The Hill's Pet Nutrition segment, encompassing Hill's Science Diet and Hill's Prescription Diet, is a key driver of revenue growth. This segment is achieving market share gains in under-developed categories like cat, wet, and small paws food. Additionally, strategic acquisitions, such as Prime 100, are contributing positively and performing ahead of expectations, further boosting the segment's performance.

AI Analysis | Feedback

Share Repurchases

  • Colgate-Palmolive authorized a new share repurchase program of up to $5 billion in March 2025, which replaced a previous $5 billion program authorized in 2022. This new program was set to commence after March 20, 2025.
  • The company's annual share repurchases amounted to $1.128 billion in 2023, $1.739 billion in 2024, and $1.21 billion in 2025.
  • Colgate-Palmolive returned $2.9 billion to shareholders through dividends and share repurchases in fiscal year 2025.

Share Issuance

  • The dollar amount of shares issued by Colgate-Palmolive was $424 million in 2021, $418 million in 2022, $380 million in 2023, and $638 million in 2024.
  • Share issuance reached its 5-year low in December 2023 at $380 million.

Inbound Investments

  • No information is available regarding large inbound investments made in Colgate-Palmolive by third-parties such as strategic partners or private equity firms over the last 3-5 years.

Outbound Investments

  • Colgate-Palmolive's net change in investments (total) was -$0.148 billion in 2022, -$0.004 billion in 2023, -$0.01 billion in 2024, and -$0.110 billion for the twelve months ending December 31, 2025.
  • The company's 2026 outlook includes disciplined mergers and acquisitions (M&A) as part of its capital allocation strategy.

Capital Expenditures

  • Colgate-Palmolive's capital expenditures were $567 million in 2021, $696 million in 2022, $705 million in 2023, $561 million in 2024, and $564 million in 2025.
  • Expected capital expenditures are $623.1 million for 2026 and are forecasted to average $736.4 million over the next five fiscal years.
  • Primary focus areas for capital expenditures and strategic investments include innovation, advertising, digital capabilities, data, analytics, and Artificial Intelligence (AI) to drive growth, efficiency, personalization, and marketing precision.

Interactive Breakdown

Colgate-Palmolive Interactive Breakdown Analysis

Better Bets vs. Colgate-Palmolive (CL)

Latest Trefis Analyses

TitleDate
0DASHBOARDS 
1Colgate-Palmolive Earnings Notes12/25/2025
2Ten-Year Tally: CL Returns $30 Bil to Shareholders10/25/2025
3Top 10 Bets In Consumer Staples Sector To Beat The Index10/18/2025
4How Low Can Colgate-Palmolive Stock Really Go?10/17/2025
5Colgate-Palmolive vs Johnson & Johnson: Which Is A Better Investment?08/18/2025
6Colgate-Palmolive vs Cal-Maine Foods: Which Is A Better Investment?08/18/2025
7Better Bet Than CL Stock: Pay Less Than Colgate-Palmolive To Get More From UNH, DIS 08/12/2025
8Better Bet Than CL Stock: Pay Less Than Colgate-Palmolive To Get More From USFD, PPC 08/12/2025
9Day 10 of Loss Streak for Colgate-Palmolive Stock with -6.6% Return (vs. -3% YTD) [7/21/2025]07/22/2025
10ARTICLES 
11How Will Colgate-Palmolive Stock React To Its Upcoming Earnings?10/30/2025
12Colgate-Palmolive Stock Pays Out $30 Bil – Investors Take Note10/25/2025
13S&P 500 Stocks Trading At 52-Week Low10/03/2025
14Buy, Sell, or Hold Colgate-Palmolive Stock?09/23/2025
15CL Stock Down -6.6% after 10-Day Loss Streak07/22/2025
Title
0DASHBOARDS
1Colgate-Palmolive Earnings Notes
2Ten-Year Tally: CL Returns $30 Bil to Shareholders
3Top 10 Bets In Consumer Staples Sector To Beat The Index
4How Low Can Colgate-Palmolive Stock Really Go?
5Colgate-Palmolive vs Johnson & Johnson: Which Is A Better Investment?
6Colgate-Palmolive vs Cal-Maine Foods: Which Is A Better Investment?
7Better Bet Than CL Stock: Pay Less Than Colgate-Palmolive To Get More From UNH, DIS 
8Better Bet Than CL Stock: Pay Less Than Colgate-Palmolive To Get More From USFD, PPC 
9Day 10 of Loss Streak for Colgate-Palmolive Stock with -6.6% Return (vs. -3% YTD) [7/21/2025]
10ARTICLES
11How Will Colgate-Palmolive Stock React To Its Upcoming Earnings?
12Colgate-Palmolive Stock Pays Out $30 Bil – Investors Take Note
13S&P 500 Stocks Trading At 52-Week Low
14Buy, Sell, or Hold Colgate-Palmolive Stock?
15CL Stock Down -6.6% after 10-Day Loss Streak

Trade Ideas

Select ideas related to CL.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
MZTI_3272026_Dip_Buyer_FCFYield03272026MZTIMarzettiDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		0.9%0.9%0.0%
TAP_3272026_Dip_Buyer_FCFYield03272026TAPMolson Coors BeverageDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		-0.8%-0.8%-1.1%
KHC_3202026_Dip_Buyer_FCFYield03202026KHCKraft HeinzDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		4.3%4.3%-1.7%
KMB_3202026_Dip_Buyer_FCFYield03202026KMBKimberly-ClarkDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		-1.8%-1.8%-1.9%
MKC_3202026_Dip_Buyer_ValueBuy03202026MKCMcCormickDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		-5.2%-5.2%-5.2%

Recent Active Movers

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons

Peers to compare with:

Financials

CLPGKMBCHDCLXGISMedian
NameColgate-.Procter .Kimberly.Church &.Clorox General . 
Mkt Price85.81146.9398.8496.88104.5835.5097.86
Mkt Cap69.1343.132.823.112.719.028.0
Rev LTM20,38285,25917,2336,2036,75818,77718,005
Op Inc LTM4,23420,1342,4891,0781,0142,9122,701
FCF LTM3,63414,8481,6391,0937781,7831,711
FCF 3Y Avg3,40715,4402,3099597342,3002,305
CFO LTM4,19819,0702,7771,2159842,3602,568
CFO 3Y Avg4,01719,0823,1841,1349503,0053,095

Growth & Margins

CLPGKMBCHDCLXGISMedian
NameColgate-.Procter .Kimberly.Church &.Clorox General . 
Rev Chg LTM1.4%1.1%-2.2%1.6%-5.7%-5.7%-0.6%
Rev Chg 3Y Avg4.3%2.0%-4.8%4.9%-1.4%-0.9%0.5%
Rev Chg Q5.8%1.5%-0.6%3.9%-0.8%-7.2%0.5%
QoQ Delta Rev Chg LTM1.4%0.4%-0.1%1.0%-0.2%-2.0%0.1%
Op Inc Chg LTM-2.2%1.3%-15.2%-7.4%-2.5%-21.7%-5.0%
Op Inc Chg 3Y Avg5.6%5.3%-1.7%2.5%14.9%-0.6%3.9%
Op Mgn LTM20.8%23.6%14.4%17.4%15.0%15.5%16.4%
Op Mgn 3Y Avg21.1%23.7%15.4%18.2%13.1%17.1%17.6%
QoQ Delta Op Mgn LTM-0.8%-0.5%0.5%-0.0%0.1%-0.9%-0.3%
CFO/Rev LTM20.6%22.4%16.1%19.6%14.6%12.6%17.9%
CFO/Rev 3Y Avg20.1%22.6%18.4%18.7%13.5%15.3%18.5%
FCF/Rev LTM17.8%17.4%9.5%17.6%11.5%9.5%14.5%
FCF/Rev 3Y Avg17.0%18.3%13.3%15.8%10.4%11.7%14.6%

Valuation

CLPGKMBCHDCLXGISMedian
NameColgate-.Procter .Kimberly.Church &.Clorox General . 
Mkt Cap69.1343.132.823.112.719.028.0
P/S3.44.01.93.71.91.02.6
P/Op Inc16.317.013.221.412.56.514.7
P/EBIT20.816.013.422.011.86.614.7
P/E32.420.916.231.416.87.518.8
P/CFO16.518.011.819.012.98.114.7
Total Yield5.7%4.8%11.2%4.4%8.3%20.3%7.0%
Dividend Yield2.6%0.0%5.1%1.2%2.4%6.9%2.5%
FCF Yield 3Y Avg5.0%4.3%5.8%4.3%4.6%7.7%4.8%
D/E0.10.10.20.10.30.70.2
Net D/E0.10.10.20.10.20.70.2

Returns

CLPGKMBCHDCLXGISMedian
NameColgate-.Procter .Kimberly.Church &.Clorox General . 
1M Rtn-2.0%0.1%0.1%1.2%-3.1%-4.0%-0.9%
3M Rtn2.1%2.4%0.7%7.2%-3.9%-18.9%1.4%
6M Rtn9.1%-1.6%-16.6%10.2%-10.8%-24.3%-6.2%
12M Rtn-8.4%-11.5%-27.7%-6.9%-22.1%-34.8%-16.8%
3Y Rtn22.0%4.9%-20.0%12.3%-27.6%-53.9%-7.5%
1M Excs Rtn-9.5%-7.4%-7.4%-6.4%-10.7%-11.5%-8.5%
3M Excs Rtn-0.2%-0.3%-3.0%4.8%-7.6%-23.4%-1.6%
6M Excs Rtn5.1%-5.7%-22.4%6.1%-16.6%-30.1%-11.1%
12M Excs Rtn-38.8%-42.4%-59.1%-38.6%-54.0%-67.2%-48.2%
3Y Excs Rtn-53.0%-69.2%-93.0%-62.3%-100.3%-127.8%-81.1%

Comparison Analyses

FDA Approved Drugs Data

Expand for More
Post-Approval Fwd Returns
FDA
App #		Brand
Name		Generic
Name		Dosage
Form		FDA
Approval		3M
Rtn		6M
Rtn		1Y
Rtn		2Y
Rtn		Total
Rtn
ANDA203212  PERIOGARDchlorhexidine gluconatesolution128201610.0%13.9%1.7%18.2%62.6%

Financials

Segment Financials

Revenue by Segment
$ Mil20252024202320222021
Oral, Personal and Home Care15,61815,16714,25414,11013,588
Pet Nutrition4,4834,2903,7133,3112,883
Total20,10119,45717,96717,42116,471


Operating Income by Segment
$ Mil20252024202320222021
Oral, Personal and Home Care4,0883,8823,3483,4953,594
Pet Nutrition965806850901793
Corporate-784-704-1,305-1,064-502
Total4,2693,9842,8933,3323,885


Price Behavior

Price Behavior
Market Price$85.81 
Market Cap ($ Bil)69.1 
First Trading Date01/03/1977 
Distance from 52W High-13.4% 
   50 Days200 Days
DMA Price$90.18$83.60
DMA Trendindeterminateup
Distance from DMA-4.8%2.6%
 3M1YR
Volatility24.7%20.6%
Downside Capture-0.01-0.07
Upside Capture13.60-20.81
Correlation (SPY)4.5%-4.4%
CL Betas & Captures as of 3/31/2026

 1M2M3M6M1Y3Y
Beta0.640.200.08-0.180.070.07
Up Beta1.880.270.160.120.160.15
Down Beta-0.290.420.470.070.08-0.02
Up Capture-7%7%3%-23%-5%2%
Bmk +ve Days7162765139424
Stock +ve Days7203263118385
Down Capture147%13%-29%-56%-1%10%
Bmk -ve Days12233358110323
Stock -ve Days15223163134361

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
Annualized
Return		Annualized
Volatility		Sharpe
Ratio		Correlation
with CL
CL-6.7%20.7%-0.44-
Sector ETF (XLP)4.0%12.7%0.0475.1%
Equity (SPY)21.1%12.9%1.32-3.7%
Gold (GLD)50.9%27.5%1.49-0.1%
Commodities (DBC)25.2%16.2%1.40-17.3%
Real Estate (VNQ)17.5%13.7%0.9336.3%
Bitcoin (BTCUSD)-10.5%42.6%-0.14-11.2%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
Annualized
Return		Annualized
Volatility		Sharpe
Ratio		Correlation
with CL
CL3.8%18.4%0.10-
Sector ETF (XLP)6.2%13.2%0.2673.8%
Equity (SPY)10.8%17.1%0.4921.5%
Gold (GLD)22.6%17.8%1.047.3%
Commodities (DBC)11.6%18.8%0.51-3.8%
Real Estate (VNQ)4.4%18.8%0.1436.6%
Bitcoin (BTCUSD)4.6%56.5%0.30-1.2%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
Annualized
Return		Annualized
Volatility		Sharpe
Ratio		Correlation
with CL
CL4.3%19.5%0.17-
Sector ETF (XLP)7.2%14.7%0.3676.3%
Equity (SPY)14.0%17.9%0.6740.3%
Gold (GLD)14.3%15.9%0.757.8%
Commodities (DBC)8.5%17.6%0.406.9%
Real Estate (VNQ)5.6%20.7%0.2447.8%
Bitcoin (BTCUSD)68.0%66.9%1.072.5%

Smart multi-asset allocation framework can stack odds in your favor. Learn How

Short Interest

Short Interest: As Of Date3312026
Short Interest: Shares Quantity21.4 Mil
Short Interest: % Change Since 31520265.0%
Average Daily Volume7.0 Mil
Days-to-Cover Short Interest3.0 days
Basic Shares Quantity804.8 Mil
Short % of Basic Shares2.7%

Returns Analyses

Earnings Returns History

Expand for More
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
1/30/20265.9%11.3%14.1%
10/31/20250.7%1.0%3.0%
8/1/2025-0.4%1.0%0.3%
4/25/20251.3%-2.2%-0.1%
1/31/2025-4.6%-5.7%2.1%
7/26/20243.0%4.6%8.0%
4/26/20241.9%4.1%4.5%
1/26/20242.0%6.0%6.1%
...
SUMMARY STATS   
# Positive121315
# Negative11108
Median Positive1.9%3.1%4.3%
Median Negative-1.9%-2.1%-3.6%
Max Positive5.9%11.3%14.1%
Max Negative-5.2%-6.3%-7.3%

SEC Filings

Expand for More
Report DateFiling DateFiling
12/31/202502/23/202610-K
09/30/202510/31/202510-Q
06/30/202508/01/202510-Q
03/31/202504/25/202510-Q
12/31/202402/13/202510-K
09/30/202410/25/202410-Q
06/30/202407/26/202410-Q
03/31/202404/26/202410-Q
12/31/202302/15/202410-K
09/30/202310/27/202310-Q
06/30/202307/28/202310-Q
03/31/202304/28/202310-Q
12/31/202202/16/202310-K
09/30/202210/28/202210-Q
06/30/202207/29/202210-Q
03/31/202204/29/202210-Q

Recent Forward Guidance [BETA]

Latest: Q4 2025 Earnings Reported 1/30/2026

Forward GuidanceGuidance Change
MetricLowMidHigh% Chg% DeltaChangePrior
2026 Net Sales Growth2.0%4.0%6.0%100.0%2.0%RaisedGuidance: 2.0% for 2025
2026 Organic Sales Growth1.0%2.5%4.0%66.7%1.0%RaisedGuidance: 1.5% for 2025

Prior: Q3 2025 Earnings Reported 10/31/2025

Forward GuidanceGuidance Change
MetricLowMidHigh% Chg% DeltaChangePrior
2025 Net Sales Growth 2.0% 0.0% AffirmedGuidance: 2.0% for 2025
2025 Organic Sales Growth 1.5% -50.0%-1.5%LoweredGuidance: 3.0% for 2025
2025 EPS Growth 2.0% 0.0% AffirmedGuidance: 2.0% for 2025
2025 Gross Profit Margin 60.1%    

Insider Activity

Expand for More
#OwnerTitleHoldingActionFiling DatePriceSharesTransacted
Value		Value of
Held Shares		Form
1Massey, SallyChief Human Resources OfficerDirectSell1124202580.891,237100,0611,112,318Form
2Massey, SallyChief Human Resources OfficerDirectSell519202588.972,250200,1831,119,511Form
3Massey, SallyChief Human Resources OfficerDirectSell227202592.028,000736,1521,362,341Form
4Sutula, Stanley J IiiChief Financial OfficerDirectSell206202694.2797,8439,223,2885,213,864Form
5Daniels, JenniferCLO and SecretaryDirectSell206202694.3422,0002,075,3997,207,859Form

External Quote Links


Prefer one of these to Trefis? Tell us why.